ILBS-IITD Collaborative Platform: MoU signed to conquer unmet medical challenges
Indian Institute of Technology (IIT), Delhi and Institute of Liver and Biliary Sciences (ILBS), Delhi have come together and signed a Memorandum of Understanding (MoU) to establish ‘ILBS-IITD Collaborative Platform’, which gives a wide-extending joint efforts that include scholastic, research, product, process and human resource development focuses on liver and biliary diseases.
The mission of this ‘ILBS-IITD Collaborative Platform’ is to identify the problems looked by the specialists rehearsing in the field of metabolic and liver ailments and to initiate work jointly with engineering and medical teams for sustainable solutions.
The scope of collaboration focusses on liver illnesses and incorporates following:
- To form intramural funding for the projects in both IIT Delhi and ILBS, to start the cooperative examination among various clinical and engineering filed
- To permit enlisted PhD students of both institution to attend lectures and courses relevant to their area of research one another's organizations and
- Mirroring joint PhD management and creating Technology Business Incubator (TBI).
As an aspect of MoU signed, there are different regions of joint effort, including, utilization of Artificial Intelligence in Liver and Biliary illnesses, bio-sensor improvement computational science and Big Data, material Sciences, liver Dialysis films and machines, 3D Bioprinting, bio-fake Liver. It will likewise incorporate cycles like the regenerative tissue development and utilization of nano-science in conclusion and powerful conveyance of the medication. In conclusion, the arrangement will likewise zero in on applied standards and plan ideas of building to medical services and foundation of an Incubation Center at ILBS.
The MoU was signed by Prof V. Ramgopal Rao, Director, IIT Delhi and Dr. SK Sarin, Director, ILBS, Delhi. Speaking about the MoU with IIT Delhi, Dr. SK Sarin, Director, ILBS, Delhi, said, “Use of computational tools, AI and biosensors are of paramount importance in real-time inference and non-invasively from a large amount of diagnostic data. He further added that ‘Team ILBS’ with data of more than 200,000 liver patients is most suited and eager for rapid strides and joint ventures with IIT Delhi.”
Prof V. Ramgopal Rao, Director, IIT Delhi, termed it as mutually beneficial partnership between the two eminent institutions having complementary expertise. He said that the “Developing specialized human resources in interdisciplinary domains bridging engineering and medicine faculty to solve some of the challenges faced by the health sector in the country will be an important goal of this Collaborative Platform. IIT Delhi researchers will bring their expertise on machine learning and AI technologies to solve some of the outstanding problems in the area of liver and biliary medicine.”